Veerle F A M Derksen
Overview
Explore the profile of Veerle F A M Derksen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Derksen V, Martinsson K, van Mourik A, Wagenaar C, Toes R, Walrabenstein W, et al.
Arthritis Rheumatol
. 2024 Oct;
77(3):272-282.
PMID: 39420623
Objective: Anti-citrullinated protein antibodies (ACPA) have been detected in sputum and saliva, indicating that anti-modified protein antibodies (AMPA) can be produced at mucosal sites in patients with rheumatoid arthritis (RA)....
2.
Kissel T, Derksen V, Bentlage A, Koeleman C, Hafkenscheid L, van der Woude D, et al.
Nat Commun
. 2024 Jan;
15(1):393.
PMID: 38195612
IgG secreted by B cells carry asparagine N(297)-linked glycans in the fragment crystallizable (Fc) region. Changes in Fc glycosylation are related to health or disease and are functionally relevant, as...
3.
Derksen V, Allaart C, van der Helm-van Mil A, Huizinga T, Toes R, van der Woude D
Rheumatology (Oxford)
. 2022 Apr;
62(1):407-416.
PMID: 35416963
Objective: Mucosal initiated immune responses may be involved in the pathophysiology of RA. The most abundant immunoglobulin at mucosal surfaces is IgA, of which two subclasses exist: IgA1 and IgA2....
4.
Reijm S, Kissel T, Stoeken-Rijsbergen G, Slot L, Wortel C, van Dooren H, et al.
Arthritis Res Ther
. 2021 Sep;
23(1):230.
PMID: 34479638
Background: Anti-modified protein antibodies (AMPA) targeting citrullinated, acetylated and/or carbamylated self-antigens are hallmarks of rheumatoid arthritis (RA). Although AMPA-IgG cross-reactivity to multiple post-translational modifications (PTMs) is evident, it is unknown...
5.
Derksen V, van der Woude D
Ann Rheum Dis
. 2021 Apr;
82(6):e137.
PMID: 33906855
No abstract available.
6.
Derksen V, Kissel T, Lamers-Karnebeek F, van der Bijl A, Venhuizen A, Huizinga T, et al.
Ann Rheum Dis
. 2021 Mar;
80(8):1096-1098.
PMID: 33648960
No abstract available.
7.
de Moel E, Derksen V, Trouw L, Bang H, Collee G, Lard L, et al.
Arthritis Res Ther
. 2019 Jan;
21(1):28.
PMID: 30658699
Background: Rheumatoid arthritis (RA) is characterized by the presence of autoantibodies like rheumatoid factor (RF), anti-cyclic citrullinated peptide-2 (anti-CCP2), and anti-carbamylated protein (anti-CarP) antibodies. It is currently unclear whether changes...
8.
de Moel E, Derksen V, Trouw L, Bang H, Goekoop-Ruiterman Y, Steup-Beekman G, et al.
Ann Rheum Dis
. 2018 Jul;
77(12):1836-1838.
PMID: 30045852
No abstract available.
9.
de Moel E, Derksen V, Stoeken G, Trouw L, Bang H, Goekoop R, et al.
Arthritis Res Ther
. 2018 Feb;
20(1):33.
PMID: 29482627
Background: The autoantibody profile of seropositive rheumatoid arthritis (RA) is very diverse and consists of various isotypes and antibodies to multiple post-translational modifications. It is yet unknown whether this varying...
10.
van Delft M, Verheul M, Burgers L, Derksen V, van der Helm-van Mil A, van der Woude D, et al.
Arthritis Res Ther
. 2017 Aug;
19(1):190.
PMID: 28810902
Background: Anti-carbamylated protein (anti-CarP) antibodies have recently been reported to occur in around 45% of rheumatoid arthritis (RA) patients and to have prognostic and diagnostic properties. At present, the breadth...